| The significance of this study was to explore the clinical effect of pelvic floor magnetoelectric combined with "1+1" treatment regimen in Chronic prostatitis Type IIIB/chronic pelvic pain syndrome(CPPS).In this study,the combination of pelvic floor magnetic and electric therapy was compared with the current common clinical drug therapy,aiming to seek a more effective,safer and non-invasive treatment for patients with chronic prostatitis type IIIB/chronic pelvic pain syndrome.Methods:A total of 40 patients diagnosed with CP/CPPS were selected from the outpatient department and inpatient department of urology department of Jingzhou Hospital Affiliated to Yangtze University and Central Hubei Regional Medical Center from December 2021 to August 2022.After the patient’s condition was informed,the patient was admitted to the outpatient clinic for urine routine examination,prostatic fluid examination,color ultrasound of urinary system to exclude other urinary system diseases and other types of prostatitis,and then signed the consent for treatment plan selection.40 patients were divided into two experimental groups A and B by random number table method,in which 20 patients in the control group received Tamsulosin hydrochloride extension-release capsules.Observation group 20 patients were treated with pelvic floor magnetoelectric combined with "1+1" treatment,2 weeks as a course of treatment,a total of 3 courses.After 3 courses of treatment,the NIH-CPSI score(including pain symptom score,urination symptom score,quality of life score),total effective rate and IPSS score after 1 month of treatment were compared between the two groups,respectively.Various adverse reactions were recorded during treatment.Results:1.Comparison of the total effective rate between the first and two groups showed that after 2.4 and 6 weeks of treatment,the total effective rate of the control group was35%,60% and 95%,respectively,while the total effective rate of the observation group was 70%,95% and 100%,which was significantly higher than that of the control group,and the difference was statistically significant(P < 0.05).2.Comparison of NIH-CPSI scores before and after treatment between the two groups,(1)Compared with the observation group before treatment [total NIH-CPSI score(28.20 ± 6.14),pain symptom score(11.20 ± 3.96),urination symptom score(7.30± 2.75),quality of life score(9.40 ± 2.21)],Observation group was treated for 2 weeks[NIH-CPSI total score(16.10 ± 7.29),pain symptom score(5.50 ± 3.28),urination symptom score(4.75 ± 2.86),quality of life score(5.80 ± 2.44)],4 weeks [NIH-CPSI total score(12.70 ± 6.07),pain symptom score(4.20 ± 2.53),urination symptom score(3.70 ± 2.27),quality of life score(4.70 ± 2.18)],6 weeks later [NIH-CPSI total score(9.45 ± 4.51),pain symptom score(3.05 ± 1.85),urination symptom score(2.75 ± 1.77),quality of life score(3.65 ± 1.79)] Pain score,urination score,quality of life score and NIH-CPSI total score were significantly improved(P < 0.05);Compared with 2 weeks of treatment,all indexes improved after 4 weeks of treatment,but the degree was not obvious,the difference was not statistically significant(P > 0.05),after 6 weeks of treatment,all indexes improved significantly,and the differences were statistically significant(P < 0.05);Compared with 4 weeks of treatment,all indexes improved after6 weeks of treatment,but the degree was not obvious,the difference was not statistically significant P > 0.(2)Compared with the control group before treatment [total NIHCPSI score(24.95 ± 5.04),pain symptom score(10.20 ± 3.64),urination symptom score(6.25 ± 2.45),quality of life score(8.30 ± 1.78)],The control group was treated for 2weeks [NIH-CPSI total score(19.55 ± 5.92),pain symptom score(7.45 ± 3.42),urination symptom score(4.95 ± 2.26),quality of life score(6.75 ± 1.92)] and 4 weeks[NIH-CPSI total score(16.25 ± 4.82),pain symptom score(6.35 ± 2.92),urination symptom score(4.05 ± 1.88),quality of life score(5.85 ± 1.57)],6 weeks [NIH-CPSI total score(14.55 ± 4.52),pain symptom score(5.45 ± 2.65),urination symptom score(3.70 ± 1.56),quality of life score(5.25 ± 1.52)] Pain score,urination score,quality of life score and NIH-CPSI total score were significantly improved(P < 0.05)(except for urinary symptom score 2 weeks after treatment);Compared with 2 weeks after treatment,all indexes improved after 4 weeks of treatment,but the degree was not obvious,the difference was not statistically significant(P > 0.05),after 6 weeks of treatment,all indexes improved significantly,and the differences were statistically significant(P < 0.05);Compared with 4 weeks of treatment,all indexes improved after6 weeks of treatment,but the degree was not obvious,the difference was not statistically significant(P > 0.05);(3)After 2 weeks,4 weeks and 6 weeks of treatment,the NIHCPSI scores and total scores in the observation group were significantly lower than those in the control group,with statistical differences(all P < 0.05).3.There was no significant difference in IPSS scores between the two groups before treatment(19.60±9.24 in the observation group and 20.10±8.29 in the control group)(P > 0.05).The IPSS score of observation group(13.65±7.08)after 1 month of treatment was lower than that of control group(16.80±7.81),and the difference was statistically significant(P < 0.05).4.During the whole treatment stage,patients in the two groups complained of no special discomfort,and no dangerous or potentially dangerous events occurred.Conclusion:In CP/CPPS patients,the effect of combined pelvic floor magnetoelectric therapy was superior to Tamsulosin hydrochloride sustained release capsules.As a safe and effective treatment for chronic prostatitis in clinical practice,pelvic floor magnetoelectric combined therapy has a better effect in alleviating patients’ symptoms and greatly improves patients’ quality of life compared with the existing traditional drug therapy.From the perspective of long-term treatment course,it is more efficient than drug therapy,which can improve patients’ symptoms for a long time.Besides,the operation is simple and non-invasive,the treatment process of patients is painless,and the side effects caused by long-term oral drugs can be avoided.Therefore,pelvic floor magnetic electrotherapy is an effective and safe way to treat CP/CPPS,and it is worth promoting in major hospitals... |
PDF Full Text Request